These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6388208)

  • 1. Abnormal growth hormone levels in insulin-dependent diabetic patients under continuous subcutaneous insulin infusion and intensified conventional treatment.
    Arias P; Kerner W; de la Fuente A; Pfeiffer EF
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):250-5. PubMed ID: 6388208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24-hour continuous blood glucose monitoring.
    Arias P; Kerner W; Zier H; Navascués I; Pfeiffer EF
    Diabetes Care; 1985; 8(2):134-40. PubMed ID: 3888562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic response to fasting exercise in adolescent insulin-dependent diabetic subjects treated with continuous subcutaneous insulin infusion and intensive conventional therapy.
    Schiffrin A; Parikh S; Marliss EB; Desrosiers MM
    Diabetes Care; 1984; 7(3):255-60. PubMed ID: 6376018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion and postprandial exercise in tightly controlled type I (insulin-dependent) diabetic patients.
    Trovati M; Carta Q; Cavalot F; Vitali S; Passarino G; Rocca G; Emanuelli G; Lenti G
    Diabetes Care; 1984; 7(4):327-30. PubMed ID: 6381005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen.
    Saurbrey N; Arnold-Larsen S; Møller-Jensen B; Kühl C
    Diabet Med; 1988 Mar; 5(2):150-3. PubMed ID: 2964981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensified insulin therapy in the type I diabetic adolescent: a controlled trial.
    Schiffrin AD; Desrosiers M; Aleyassine H; Belmonte MM
    Diabetes Care; 1984; 7(2):107-13. PubMed ID: 6376006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal growth hormone responses to hypoglycemia and exercise in adults with type I diabetes.
    Shilo S; Shamoon H
    Isr J Med Sci; 1990 Mar; 26(3):136-41. PubMed ID: 2184144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous subcutaneous insulin infusion treatment in insulin-dependent diabetic patients: a comparison with conventional optimized treatment in a long-term study.
    Calabrese G; Bueti A; Santeusanio F; Giombolini A; Zega G; Angeletti G; Cartechini MG; Brunetti P
    Diabetes Care; 1982; 5(5):457-65. PubMed ID: 7188333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic control in newly kidney transplanted insulin-dependent diabetics: improvement by insulin pump treatment (CSII).
    Schmitz O; Sorensen SS; Alberti KG; Orskov H; Hansen HE
    J Diabet Complications; 1987; 1(3):81-6. PubMed ID: 2969910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusion.
    Hermansen K; Schmitz O; Boye N; Christensen CK; Christiansen JS; Alberti KG; Orskov H; Mogensen CE
    Metabolism; 1988 Jul; 37(7):640-4. PubMed ID: 3290622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
    Buysschaert M; Lejeune M; Lambert AE
    Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin pump treatment: effect on glucose homeostasis, metabolites, hormones, insulin antibodies and quality of life.
    Beck-Nielsen H; Richelsen B; Schwartz Sørensen N; Hother Nielsen O
    Diabetes Res; 1985 Jan; 2(1):37-43. PubMed ID: 3888495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deranged alpha-adrenergic regulation of growth hormone secretion in poorly controlled diabetes: reversal of the exaggerated response to clonidine after continuous subcutaneous insulin infusion.
    Topper E; Gertner J; Amiel S; Press M; Genel M; Tamborlane WV
    Pediatr Res; 1985 Jun; 19(6):534-6. PubMed ID: 2989759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous basal insulin infusion without premeal boluses in insulin-dependent diabetes mellitus therapy.
    Cimino A; Valentini U; Rotondi A; Candrina R; Salvi A; Spandrio S; Radaeli E; Giustina G
    Acta Diabetol Lat; 1987; 24(3):193-8. PubMed ID: 3318256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of continuous subcutaneous insulin infusion on insulin binding to erythrocytes in diabetes mellitus.
    Ng FM; Babacan E; Cohen M; Zimmet PZ
    Diabetes Res Clin Pract; 1987; 3(1):31-7. PubMed ID: 3545728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nine years' personal experience of intensified diabetes control: infusion versus injections.
    Jarrett AM
    Diabet Med; 1986; 3(6):552-6. PubMed ID: 2951212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free insulin profiles during intensive treatment with biosynthetic human insulin.
    Olsson PO; Arnqvist HJ; Von Schenck HV
    Diabete Metab; 1988; 14(3):253-8. PubMed ID: 3044863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of intensified insulin therapy.
    Brunetti P; Bueti A; Antonella MA; Calabrese G; Fabietti PG; Santeusanio F; Massi Benedetti M
    Exp Clin Endocrinol; 1984 Apr; 83(2):130-5. PubMed ID: 6373314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemia and counterregulation in insulin-dependent diabetic patients: a comparison of continuous subcutaneous insulin infusion and conventional insulin injection therapy.
    Ng Tang Fui S; Pickup JC; Bending JJ; Collins AC; Keen H; Dalton N
    Diabetes Care; 1986; 9(3):221-7. PubMed ID: 3525052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII.
    Koivisto VA; Yki-Järvinen H; Helve E; Karonen SL; Pelkonen R
    Diabetes; 1986 Jan; 35(1):78-82. PubMed ID: 3510143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.